Kaiser Permanente Washington researchers are exploring how to improve prevention and treatment of health issues due to alcohol and other drug use. The addictions research group conducts innovative research to help patients and their providers prevent and treat problems caused by alcohol, cannabis, opioids, and other drugs in health settings.
A major focus of the addictions research group is how to integrate patient-centered care for alcohol and other drug use into medical settings. For more than 3 decades, their work has focused on the need for health systems to routinely measure and address alcohol and other drug use as part of whole-person health, in nonjudgmental, patient-centered ways.
"Our alcohol-related research has built tools — such as a brief video, handout, and a patient decision aid — that help overcome stigma so that patients and families can find the help they want and need," said Katharine A. Bradley, MD, MPH, a senior investigator at Kaiser Permanente Washington Health Research Institute (KPWHRI) and internal medicine physician with Washington Permanente Medical Group.
The addictions research group is conducting a variety of studies to improve measures and documentation of substance use in the medical record. "We are working to find ways to easily document the extent of cannabis exposure for both medical and nonmedical use in electronic health records," said Gwen Lapham, PhD, MSW, a KPWHRI assistant investigator. Finding innovative ways to provide treatment is also a focus. "We are testing how to get proven online treatments for addiction into the hands of patients who could benefit," said Joseph E. Glass, PhD, MSW, a KPWHRI associate investigator whose research at the institute is funded in part by an early-career award to study the effectiveness of treatments for alcohol use disorders in primary care.
These are among the group’s current studies:
These are among the studies that the addictions research group has completed:
The SPARC trial successfully implemented behavioral health care into primary care. On our website, you can access tools for behavioral health integration, as well as frequently asked questions and publications.
Wartko PD, Bobb JF, Boudreau DM, Matthews AG, McCormack J, Lee AK, Qiu H, Yu O, Hyun N, Idu AE, Campbell CI, Saxon AJ, Liu DS, Altschuler A, Samet JH, Labelle CT, Zare-Mehrjerdi M, Stotts AL, Braciszewski JM, Murphy MT, Dryden D, Arnsten JH, Cunningham CO, Horigian VE, Szapocznik J, Glass JE, Caldeiro RM, Phillips RC, Shea M, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Lapham GT, Addis M, Bradley KA; PROUD Trial Collaborators; Ghiroli MM, Hamilton LK, Hu Y, LaHue JS, Loree AM, Murphy SM, Northrup TF, Shmueli-Blumberg D, Silva AJ, Weinstein ZM, Wong MT, Burganowski RP. Nurse care management for opioid use disorder treatment: The PROUD cluster randomized clinical trial. JAMA Intern Med. 2023 Oct 30:e235701. doi: 10.1001/jamainternmed.2023.5701. [Epub ahead of print]. PubMed
Chen AT, Johnny S, Chaliparambil R, Wong S, Glass JE. Considering the role of information and context in promoting health-related behavioral change. Proc Assoc Inf Sci Technol. 2023;60(1):908-910. doi: 10.1002/pra2.894. Epub 2023 Oct 22. PubMed
Frost MC, Malte CA, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. J Subst Use Addict Treat. 2023 Dec:155:209175. doi: 10.1016/j.josat.2023.209175. Epub 2023 Sep 24. PubMed
McNeely J, McLeman B, Gardner T, Nesin N, Amarendran V, Farkas S, Wahle A, Pitts S, Kline M, King J, Rosa C, Marsch L, Rotrosen J, Hamilton L. Implementation of substance use screening in rural federally-qualified health center clinics identified high rates of unhealthy alcohol and cannabis use among adult primary care patients. Addict Sci Clin Pract.. 2023 Sep 20;18(1):56. doi: 10.1186/s13722-023-00404-y. PubMed
Wartko PD, Krakauer C, Turner JA, Cook AJ, Boudreau DM, Sullivan MD. STRategies to Improve Pain and Enjoy life (STRIPE): Results of a pragmatic randomized trial of pain coping skills training and opioid medication taper guidance for patients on long-term opioid therapy. Pain. 2023 Dec 1;164(12):2852-2864. doi: 10.1097/j.pain.0000000000002982. Epub 2023 Aug 25. PubMed
Jennifer F. Bobb, PhDAssociate Biostatistics Investigator |
Katharine A. Bradley, MD, MPHSenior Investigator |
Joseph E. Glass, PhD, MSWAssociate Investigator |
Clarissa Hsu, PhDAssociate Investigator |
Gwen Lapham, PhD, MPH, MSWAssistant Investigator |
Jennifer B. McClure, PhDDirector, Investigative Science |
Julie E. Richards, PhD, MPHAssistant Investigator |
Paige D. Wartko, PhD, MPHSenior Collaborative Scientist |
Yu-Ru Su, PhDAssociate Biostatistics Investigator |
Leah K. Hamilton, PhDSenior Collaborative Scientist |
Noorie Hyun, PhDAssociate Biostatistics Investigator |
Jess Mogk, MPHCollaborative Scientist |
Morgan Justice, MACollaborative Scientist |
Theresa E. Matson, PhD, MPHCollaborative Scientist |
Kevin Hallgren, PhD
Associate Professor
Department of Psychiatry and Behavioral Sciences
University of Washington
Emily Williams, PhD, MPH
Investigator
Health Services Research & Development
VA Puget Sound Health Care System
Edwin Wong, PhD
Associate Professor
Department of Health Services and Population Health
University of Washington